Show simple item record

dc.contributor.authorWehmeyer, Alexander
dc.contributor.authorCoetzee, R
dc.contributor.authorMcCartney, J
dc.date.accessioned2022-04-25T10:22:23Z
dc.date.available2022-04-25T10:22:23Z
dc.date.issued2022
dc.identifier.citationWehmeyer, A. et al. (2022). Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa. South African Medical Journal, 112(2), 117-123. https://doi.org/10.7196/SAMJ.2022.v112i2.16040en_US
dc.identifier.issn2078-5135
dc.identifier.urihttps://doi.org/10.7196/SAMJ.2022.v112i2.16040
dc.identifier.urihttp://hdl.handle.net/10566/7322
dc.description.abstractVenous thromboembolism (VTE) is regarded as the most preventable cause of inpatient death in hospital settings globally. VTE can be prevented through the provision of non-pharmacological and/or pharmacological thromboprophylaxis following individualised risk screening. The Caprini risk assessment model (RAM) offers a validated and well-established approach for VTE risk assessment in medical inpatients. Literature findings describe a trend towards inappropriate and under-prescribing of thromboprophylaxis in this population. Together with concerns regarding clinicians’ perceived importance of VTE risk assessment, the need to clarify these aspects of practice is evident. To describe VTE risk assessment and prophylaxis practices of medical practitioners in public sector hospitals in Western Cape Province, South Africa (SA).en_US
dc.language.isoenen_US
dc.publisherSouth African Medical Associationen_US
dc.subjectVenous thromboembolismen_US
dc.subjectMedical patientsen_US
dc.subjectCape Town metropoleen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectPharmacyen_US
dc.titleVenous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record